Thurein Htoo

Thurein Htoo is the Chief Executive Officer and Co-Founder of Qlaris Bio. Thurein Htoo is a biopharmaceutical strategist primarily focused in ophthalmology and rare disease. He was previously the Chief Business Officer of Qrativ. Before Qrativ, he was VP, Head of Business Development and Corporate Strategy at Novelion Therapeutics where he had helped orchestrate the merger of QLT Inc. and Aegerion Pharmaceuticals to form Novelion. Thurein Htoo has also held leadership roles encompassing business development and disease area strategy in Ophthalmology and Rare Diseases at Pfizer and at NPS Pharmaceuticals.

Thurein Htoo is the Co-Founder and Chief Executive Officer at Qlaris Bio, based in United States, North America. With a background in Biotechnology, Thurein Htoo has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.